Funding The study was supported by the Suzhou Key Laboratory (SZS2024016), Youth Talent Support Project of Jiangsu Provincial 333 Project [(2022)329-052], Research Project of Jiangsu Commission of Health (M2020031), Elderly Health Research Project of Jiangsu Commission of Health (LR2022015, LKZ2023020), Yangzhou Basic Research Program (Joint Special Project) Health Project (20242-19), Guidance Project of Jiangsu Provincial Health Commission (Z2023074), and Science foundation of Kangda college of Nanjing medical university (KD2023KYJJ130)
Monotherapy In the LEAD-3 trial, both doses of liraglutide as monotherapy demonstrated significant improvements in glycemic control in comparison with glimepiride ( Table 19 - 5 )
Youre not who you were, but not sure who you are now
The learning curve, while modest, does require initial investment in understanding proper protocols
TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection
This helps you avoid problems and get the full benefit out of your medicine every time